Back to Screener

Consumer Defensive

Meiji Holdings Co., Ltd.(MEJHY)

Live Price

Offline

$11.20

+0.00% today

1Y Change

+4.57%

Window

Jun 25, 2025 โ†’ Jun 24, 2026

Market Cap
$1.01T
Revenue Growth
+4.4%
EPS Growth
+2.4%
Dividend Yield
2.8%

Coverage: 251 bars ยท Jun 25, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Meiji Holdings Co., Ltd. (MEJHY) is a Consumer Defensive stock with a market cap of $1.01T and listed on OTC. The stock last traded around $11.20 and up 4.6% across the available one-year price window (Jun 25, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of +4.4%, EPS growth of +2.4%, a dividend yield of 2.8%. What stands out right now is revenue +4.4%, EPS +2.4%, free cash flow -77.3% with operating margin 7.6% and ROIC 5.4%. The dividend matters to the case here, with a current yield around 2.8%. Valuation is more restrained than many high-expectation growth names at P/E 21.9 and price/sales 0.9. Stock Foundry combines MEJHY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+4.4% vs +1.7% peer median

Operating Margin

Near sector median

+7.6% vs +6.6% peer median

P/E

Above sector median

21.9 vs 14.0 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 7, 2026, but the surprise data is still limited.

The operating story is still moving forward

Revenue is running at +4.4% and EPS at +2.4%, with operating margin around 7.6%.

Shareholder return is still part of the story

The stock is still offering a dividend yield around 2.8%, which matters if the thesis depends on income as much as growth.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged +1.4% over the next 5 trading days and finished higher after 2 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 7, 2026
โ€”+0.0%+0.0%-4.0%
2026
Feb 9, 2026
โ€”+2.6%+2.6%-0.7%
2025
Nov 10, 2025
โ€”+4.4%+1.6%-6.2%

Benchmark Edge

MEJHY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

MEJHY

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

MEJHY Max Drawdown

-28.47%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for MEJHY and SPY.

Calendar-year return history is still loading or unavailable.
Meiji Holdings Co., Ltd. logo

Company Overview

Meiji Holdings Co., Ltd.

Other OTC

Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter and margarine, cream, ice cream, ready meals, chocolates, gummy products, chewing gums, sports nutrition products, infant formula, liquid diet, beauty supplements, OTC medicines, feed stuffs, corn sweeteners, and sugar, as well as transportation and distribution services. The company also offers drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and animal vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, disinfectants, oral administration, insecticides, anthelmintic, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents. In addition, it provides insecticides, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.

Leadership
Katsunari Matsuda
IPO Date
Feb 6, 2014
Employees
17.3k
Street Address
2-4-16, Kyobashi
Mailing
Tokyo, 104-0031
Region
Tokyo, JP
Reporting Currency
USD
Investor Line
81 3 3273 4001
Last Updated
May 2, 2026
CIK: 0001558812ISIN: US5852651018
ADR ListedReports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
21.9
EV/EBITDA
7.9
Price/Sales
0.9
Price/Book
1.3

Growth

Revenue
+4.4%
EPS
+2.4%
Free Cash Flow
-77.3%

Profitability

Gross Margin
30.2%
Operating Margin
7.6%
Net Margin
4.0%
ROE
6.1%
ROIC
5.4%

Balance Sheet

Debt/Equity
0.19
Current Ratio
1.68

Earnings Reports

๐Ÿ“… Last reportedMay 7, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 7, 26
โ€”
Est โ€”
โ€”
โ€”
Est 1814270.0B
โ€”
โ€”
Feb 9, 26
0.21
Est โ€”
โ€”
1997203.0B
Est 1989334.0B
+0.4%
โ€”
Nov 10, 25
0.14
Est โ€”
โ€”
2043233.3B
Est โ€”
โ€”
โ€”
Aug 11, 25
0.13
Est โ€”
โ€”
1889078.8B
Est 2024638.2B
-6.7%
โ€”
May 8, 25
0.09
Est โ€”
โ€”
1918739.6B
Est 1929760.3B
-0.6%
โ€”
Feb 10, 25
0.20
Est โ€”
โ€”
1946287.2B
Est 1867243.0B
+4.2%
โ€”
Nov 11, 24
0.16
Est โ€”
โ€”
1952109.7B
Est โ€”
โ€”
โ€”
Aug 9, 24
0.16
Est โ€”
โ€”
1735211.1B
Est โ€”
โ€”
โ€”
May 10, 24
0.07
Est โ€”
โ€”
1796260.7B
Est โ€”
โ€”
โ€”
Feb 8, 24
0.22
Est โ€”
โ€”
2051243.5B
Est โ€”
โ€”
โ€”
Sep 30, 23
0.20
Est โ€”
โ€”
1895836.2B
Est โ€”
โ€”
โ€”
Jun 30, 23
0.14
Est โ€”
โ€”
1817987.9B
Est โ€”
โ€”
โ€”
Mar 31, 23
0.30
Est โ€”
โ€”
1992966.5B
Est โ€”
โ€”
โ€”
Dec 31, 22
0.19
Est โ€”
โ€”
2162953.7B
Est โ€”
โ€”
โ€”
Sep 30, 22
0.21
Est โ€”
โ€”
1870010.3B
Est โ€”
โ€”
โ€”
Jun 30, 22
0.21
Est โ€”
โ€”
1818184.0B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.